{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:03:09Z","timestamp":1789167789567,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"am","delay-in-days":400,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.gofs.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T12:29:18Z","timestamp":1552480158000},"page":"418-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prise en charge th\u00e9rapeutique des infections g\u00e9nitales hautes non compliqu\u00e9es. RPC infections g\u00e9nitales hautes CNGOF et SPILF"],"prefix":"10.1016","volume":"47","author":[{"given":"R.","family":"Verdon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gofs.2019.03.008_bib0480","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2015.11.028","article-title":"Updated French guidelines for diagnosis and management of pelvic inflammatory disease","volume":"134","author":"Brun","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.gofs.2019.03.008_bib0485","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jgyn.2012.09.011","article-title":"Management of uncomplicated pelvic inflammatory disease","volume":"41","author":"Bourret","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"47","key":"10.1016\/j.gofs.2019.03.008_bib0490","article-title":"Diagnostic d\u2019une infection g\u00e9nitale haute\u00a0: crit\u00e8res cliniques, paracliniques, imagerie et c\u0153lioscopie. RPC infections g\u00e9nitales hautes CNGOF et SPILF","author":"Charveriat","year":"2019","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0495","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1086\/511424","article-title":"Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and prevention sexually transmitted diseases treatment guidelines","volume":"44","author":"Walker","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0500","doi-asserted-by":"crossref","first-page":"561909","DOI":"10.1155\/2011\/561909","article-title":"Treatment of acute pelvic inflammatory disease","volume":"2011","author":"Sweet","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2019.03.008_bib0505","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.idc.2013.08.004","article-title":"Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment","volume":"27","author":"Mitchell","year":"2013","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.gofs.2019.03.008_bib0510","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2015.05.004","article-title":"A review of antibiotic therapy for pelvic inflammatory disease","volume":"46","author":"Duarte","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.gofs.2019.03.008_bib0515","first-page":"CD010285","article-title":"Antibiotic therapy for pelvic inflammatory disease","volume":"4","author":"Savaris","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2019.03.008_bib0520","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/168.4.969","article-title":"Pelvic inflammatory disease: meta-analysis of antimicrobial regimen efficacy","volume":"168","author":"Walker","year":"1993","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.gofs.2019.03.008_bib0525","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westr\u00f6m","year":"1992","journal-title":"Sex Transm Dis"},{"issue":"201 Suppl. 2","key":"10.1016\/j.gofs.2019.03.008_bib0530","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"15","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0535","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.AOG.0000175193.37531.6e","article-title":"Effectiveness of treatment strategies of some women with pelvic inflammatory disease. A randomized trial","volume":"106","author":"Ness","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0540","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1067\/mob.2003.87","article-title":"Endometritis does not predict reproductive morbidity after pelvic inflammatory disease","volume":"188","author":"Haggerty","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0545","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/infdis\/158.3.510","article-title":"Etiology and outcome of acute pelvic inflammatory disease","volume":"158","author":"Brunham","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0550","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0002-9378(11)90626-7","article-title":"Long-term sequelae of acute pelvic inflammatory disease. A retrospective cohort study","volume":"166","author":"Safrin","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2019.03.008_bib0555","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0002-9378(11)90790-X","article-title":"Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility","volume":"168","author":"Hillis","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0560","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gofs.2019.03.008_bib0565","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462417744099","article-title":"2017 European guideline for the management of pelvic inflammatory disease","volume":"29","author":"Ross","year":"2018","journal-title":"Int J STD AIDS"},{"issue":"RR-03","key":"10.1016\/j.gofs.2019.03.008_bib0570","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.gofs.2019.03.008_bib0575","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/423963","article-title":"Bacterial vaginosis and anaerobic bacteria are associated with endometritis","volume":"39","author":"Haggerty","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"47","key":"10.1016\/j.gofs.2019.03.008_bib0580","article-title":"Les infections g\u00e9nitales hautes\u00a0: diagnostic microbiologique. RPC infections g\u00e9nitales hautes CNGOF et SPILF","author":"Cazanave","year":"2019","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"11","key":"10.1016\/j.gofs.2019.03.008_bib0585","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.gyobfe.2003.05.001","article-title":"Genital mycoplasmas","volume":"31","author":"Judlin","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gofs.2019.03.008_bib0590","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0595","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-104-2-187","article-title":"Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin","volume":"104","author":"Wasserheit","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gofs.2019.03.008_bib0600","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1471-0528.1987.tb03125.x","article-title":"Microbiological and histopathological findings in acute pelvic inflammatory disease","volume":"94","author":"Paavonen","year":"1987","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0605","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0002-9378(94)70094-X","article-title":"Observations concerning the microbial etiology of acute salpingitis","volume":"170","author":"Soper","year":"1994","journal-title":"Am J Obst Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0610","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9378(96)70158-8","article-title":"Role of bacterial vaginosis-associated microorganisms in endometritis","volume":"175","author":"Hillier","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0615","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1258\/ijsa.2011.011066","article-title":"Difficulties experienced in defining the microbial cause of pelvic inflammatory disease","author":"Taylor-Robinson","year":"2012","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.gofs.2019.03.008_bib0620","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciu220","article-title":"Azithromycin versus doxycycline for the treatment of genital Chlamydia infection: a meta-analysis of randomized controlled trials","volume":"59","author":"Kong","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0625","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12879-015-1030-9","article-title":"Treatment challenges for urogenital and anorectal Chlamydia trachomatis","volume":"15","author":"Kong","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0630","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/0002-9378(91)91479-G","article-title":"A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis","volume":"164","author":"Wendel","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0635","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007611-199306000-00002","article-title":"Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group","volume":"86","author":"Martens","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/j.gofs.2019.03.008_bib0640","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/sti.2005.019109","article-title":"Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double-blind, randomised trial","volume":"82","author":"Ross","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"10","key":"10.1016\/j.gofs.2019.03.008_bib0645","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1258\/ijsa.2008.008495","article-title":"A randomized double-blind comparison of moxifloxacin and doxycycline\/metronidazole\/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease","volume":"20","author":"Heystek","year":"2009","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.gofs.2019.03.008_bib0650","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1471-0528.2010.02687.x","article-title":"Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study","volume":"117","author":"Judlin","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2019.03.008_bib0655","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejogrb.2013.08.012","article-title":"Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial","volume":"171","author":"A\u015ficio\u011flu","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0660","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2217\/fmb.15.40","article-title":"Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance","volume":"10","author":"de Lastours","year":"2015","journal-title":"Future Microbiol"},{"issue":"21","key":"10.1016\/j.gofs.2019.03.008_bib0665","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.21.1800264","article-title":"Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017","volume":"23","author":"Poncin","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.gofs.2019.03.008_bib0670","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12879-017-2707-z","article-title":"Overall low extended-spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015","volume":"17","author":"Cole","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0675","series-title":"Ur\u00e9trites et cervicites non compliqu\u00e9es\u00a0: strat\u00e9gie diagnostique et th\u00e9rapeutique de prise en charge","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","year":"2015"},{"key":"10.1016\/j.gofs.2019.03.008_bib0680","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.gofs.2019.03.008_bib0685","unstructured":"2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease. https:\/\/www.bashhguidelines.org\/media\/1195\/gc-draft-for-consultation.pdf."},{"key":"10.1016\/j.gofs.2019.03.008_bib0690","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u00a0\u2013\u00a0the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0695","first-page":"959816","article-title":"Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease","author":"Haggerty","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0700","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10096-017-2969-9","article-title":"Multidrug-resistant Mycoplasma genitalium infections in Europe","volume":"36","author":"Braam","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0705","doi-asserted-by":"crossref","first-page":"e61481","DOI":"10.1371\/journal.pone.0061481","article-title":"Treatment of Mycoplasma genitalium. Observations form a STD clinics","volume":"8","author":"Anagrius","year":"2013","journal-title":"Plos ONE"},{"key":"10.1016\/j.gofs.2019.03.008_bib0710","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jdv.13850","article-title":"2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0715","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/sextrans-2016-053060","article-title":"Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis","volume":"94","author":"Horner","year":"2018","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.gofs.2019.03.008_bib0720","unstructured":"Observatoire national de l\u2019\u00e9pid\u00e9miologie de la r\u00e9sistance bact\u00e9rienne aux antibiotiques (ONERBA). Rapport d\u2019activit\u00e9 2017\/Annual Report 2017. http:\/\/www.onerba.org\/."},{"issue":"1","key":"10.1016\/j.gofs.2019.03.008_bib0725","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40792-015-0069-6","article-title":"Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteria","volume":"1","author":"Tokumaru","year":"2015","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.gofs.2019.03.008_bib0730","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0255-0857(21)03071-1","article-title":"Role of anaerobes in acute pelvic inflammatory disease","volume":"21","author":"Saini","year":"2003","journal-title":"Ind J Med Microbiol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2018.03.005","article-title":"Practice guidelines for the management of adult community-acquired urinary tract infections","author":"Caron","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.gofs.2019.03.008_bib0740","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1086\/425929","article-title":"Detection of novel organisms associated with salpingitis, by use of 16S rDNA polymerase chain reaction","volume":"190","author":"Hebb","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0745","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/sextrans-2015-052285","article-title":"Identification of novel microbes associated with pelvic inflammatory disease and infertility","volume":"92","author":"Haggerty","year":"2016","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.gofs.2019.03.008_bib0750","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/CMR.00086-12","article-title":"Antianaerobic antimicrobials: spectrum and susceptibility testing","volume":"26","author":"Brook","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.gofs.2019.03.008_bib0755","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/JCM.41.6.2788-2790.2003","article-title":"Tubo-ovarian abscess caused by atopobium vaginae following transvaginal oocyte recovery","volume":"41","author":"Geissd\u00f6rfer","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"S1","key":"10.1016\/j.gofs.2019.03.008_bib0760","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","article-title":"Current treatment of bacterial vaginosis\u2014limitations and need for innovation","volume":"214","author":"Bradshaw","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0765","first-page":"66","article-title":"A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease","volume":"60","author":"Heinonen","year":"1989","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.gofs.2019.03.008_bib0770","first-page":"696","article-title":"Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin","volume":"78","author":"Thadepalli","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0775","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/clinids\/24.2.170","article-title":"Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients","volume":"24","author":"Arredondo","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0780","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000268801.90261.27","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease. A randomized controlled trial","volume":"110","author":"Savaris","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0785","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ajog.2017.08.081","article-title":"Impact of metronidazole on clearance of anaerobes in women with acute pelvic inflammatory disease: the ACE trial (NCT01160640). [abstract]","volume":"217","author":"Wiesenfeld","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0790","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10096-017-2913-z","article-title":"Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial","volume":"36","author":"Cao","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0795","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jiac.2014.04.001","article-title":"Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women","volume":"20","author":"Mikamo","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.gofs.2019.03.008_bib0800","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial","volume":"186","author":"Ness","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0805","first-page":"867","article-title":"A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease","volume":"75","author":"Walters","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0810","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/clinids\/19.4.720","article-title":"Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease","volume":"19","author":"Hemsell","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.gofs.2019.03.008_bib0815","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1093\/clinids\/24.Supplement_2.S222","article-title":"A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women","volume":"24","author":"Hemsell","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0820","first-page":"7","article-title":"A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease","volume":"72","author":"Soper","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0825","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0002-9378(91)90528-Y","article-title":"Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease","volume":"164","author":"Landers","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"5A","key":"10.1016\/j.gofs.2019.03.008_bib0830","doi-asserted-by":"crossref","first-page":"142S","DOI":"10.1016\/0002-9343(89)90045-4","article-title":"Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin","volume":"87","author":"Crombleholme","year":"1989","journal-title":"Am J Med"},{"issue":"5A","key":"10.1016\/j.gofs.2019.03.008_bib0835","doi-asserted-by":"crossref","first-page":"148S","DOI":"10.1016\/0002-9343(89)90046-6","article-title":"Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection","volume":"87","author":"Apuzzio","year":"1989","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.gofs.2019.03.008_bib0840","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-198600312-00003","article-title":"Sulbactam\/ampicillin versus metronidazole\/gentamicin in the treatment of severe pelvic infections","volume":"31","author":"Crombleholme","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.gofs.2019.03.008_bib0845","first-page":"941","article-title":"A comparison of the efficacy of and tolerance of Augmentin used alone and as one of three drugs used to treat acute upper genital tract infections. Results of a multicentre trial 152 cases","volume":"17","author":"Giraud","year":"1989","journal-title":"Contracept Fertil Sex"},{"key":"10.1016\/j.gofs.2019.03.008_bib0850","first-page":"699","article-title":"Amoxicillin-clavulanic acid combination versus triple drug therapy for the treatment of acute salpingitis","volume":"84","author":"Buisson","year":"1989","journal-title":"Rev Fr Gynecol Obstet"},{"key":"10.1016\/j.gofs.2019.03.008_bib0855","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1155\/S1064744993000286","article-title":"Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: ampicillin\/sulbactam vs. cefoxitin","volume":"1","author":"Hemsell","year":"1993","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0860","unstructured":"European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. http:\/\/www.ema.europa.eu\/documents\/referral\/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf."},{"key":"10.1016\/j.gofs.2019.03.008_bib0865","doi-asserted-by":"crossref","first-page":"e020974","DOI":"10.1136\/bmjopen-2017-020974","article-title":"Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea","volume":"8","author":"Cho","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.gofs.2019.03.008_bib0870","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciu914","article-title":"Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and \u03b2-lactam\/\u03b2-lactamase inhibitors: a Taiwanese nationwide study","volume":"60","author":"Chou","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0875","first-page":"71","article-title":"Moxifloxacin safety: an analysis of 14 years of clinical data","volume":"12","author":"Tulkens","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.gofs.2019.03.008_bib0880","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease","volume":"31","author":"Bevan","year":"2003","journal-title":"J Int Med Res"},{"key":"10.1016\/j.gofs.2019.03.008_bib0885","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/OLQ.0000000000000631","article-title":"Mycoplasma genitalium macrolide and fluoroquinolone resistance: prevalence and risk factors among a 2013\u20132014 cohort of patients in Barcelona, Spain","volume":"44","author":"Barber\u00e1","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"Suppl. A","key":"10.1016\/j.gofs.2019.03.008_bib0890","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/26.suppl_A.37","article-title":"Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease","volume":"26","author":"Martens","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.gofs.2019.03.008_bib0895","series-title":"Guidelines for the management of sexually transmitted infections","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.gofs.2019.03.008_bib0900","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1258\/095646202760159710","article-title":"Pelvic inflammatory disease in the People's Republic of China: aetiology and management","volume":"13","author":"Hong","year":"2002","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.gofs.2019.03.008_bib0905","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/154099904323016446","article-title":"Adherence to oral therapies in pelvic inflammatory disease","volume":"13","author":"Dunbar-Jacob","year":"2004","journal-title":"J Womens Health"},{"key":"10.1016\/j.gofs.2019.03.008_bib0910","doi-asserted-by":"crossref","first-page":"400","DOI":"10.12688\/f1000research.13600.1","article-title":"Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review","volume":"7","author":"Abraha","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.gofs.2019.03.008_bib0915","series-title":"Principes g\u00e9n\u00e9raux et conseils de prescription des antibiotiques en premier recours","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","year":"2014"},{"key":"10.1016\/j.gofs.2019.03.008_bib0920","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.contraception.2012.08.011","article-title":"Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2019.03.008_bib0925","first-page":"806","article-title":"Contraception intra-ut\u00e9rine. RPC contraception CNGOF","volume":"46","author":"Vidal","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0930","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/314465","article-title":"Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study","volume":"178","author":"Cohen","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.008_bib0935","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9378(99)70378-9","article-title":"Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy","volume":"181","author":"Bukusi","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0940","first-page":"525","article-title":"Influence of human immunodeficiency virus infection on pelvic inflammatory disease","volume":"95","author":"Irwin","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0945","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.AOG.0000207597.70524.e8","article-title":"Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis","volume":"107","author":"Mugo","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.008_bib0950","series-title":"Recommandations de bonne pratique. Antibioth\u00e9rapie par voie g\u00e9n\u00e9rale en pratique courante dans les infections respiratoires hautes de l\u2019adulte et l\u2019enfant. Argumentaire","author":"AFSSAPS","year":"2011"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718919301114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718919301114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:38:31Z","timestamp":1762853911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718919301114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2468718919301114"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2019.03.008","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge th\u00e9rapeutique des infections g\u00e9nitales hautes non compliqu\u00e9es. RPC infections g\u00e9nitales hautes CNGOF et SPILF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 CNGOF and SPILF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}